2024-04-012025-03-312025-03-31false14129774Brows and Aesthetics by Lou Limited2025-12-12falseiso4217:GBPxbrli:pure141297742024-03-31141297742025-03-31141297742024-04-012025-03-31141297742023-05-31141297742024-03-31141297742023-06-012024-03-3114129774bus:SmallEntities2024-04-012025-03-3114129774bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3114129774bus:AbridgedAccounts2024-04-012025-03-3114129774bus:PrivateLimitedCompanyLtd2024-04-012025-03-3114129774core:WithinOneYear2025-03-3114129774core:AfterOneYear2025-03-3114129774core:WithinOneYear2024-03-3114129774core:AfterOneYear2024-03-3114129774core:ShareCapital2025-03-3114129774core:SharePremium2025-03-3114129774core:RevaluationReserve2025-03-3114129774core:OtherReservesSubtotal2025-03-3114129774core:RetainedEarningsAccumulatedLosses2025-03-3114129774core:ShareCapital2024-03-3114129774core:SharePremium2024-03-3114129774core:RevaluationReserve2024-03-3114129774core:OtherReservesSubtotal2024-03-3114129774core:RetainedEarningsAccumulatedLosses2024-03-3114129774core:LandBuildings2025-03-3114129774core:PlantMachinery2025-03-3114129774core:Vehicles2025-03-3114129774core:FurnitureFittings2025-03-3114129774core:OfficeEquipment2025-03-3114129774core:NetGoodwill2025-03-3114129774core:IntangibleAssetsOtherThanGoodwill2025-03-3114129774core:ListedExchangeTraded2025-03-3114129774core:UnlistedNon-exchangeTraded2025-03-3114129774core:LandBuildings2024-03-3114129774core:PlantMachinery2024-03-3114129774core:Vehicles2024-03-3114129774core:FurnitureFittings2024-03-3114129774core:OfficeEquipment2024-03-3114129774core:NetGoodwill2024-03-3114129774core:IntangibleAssetsOtherThanGoodwill2024-03-3114129774core:ListedExchangeTraded2024-03-3114129774core:UnlistedNon-exchangeTraded2024-03-3114129774core:LandBuildings2024-04-012025-03-3114129774core:PlantMachinery2024-04-012025-03-3114129774core:Vehicles2024-04-012025-03-3114129774core:FurnitureFittings2024-04-012025-03-3114129774core:OfficeEquipment2024-04-012025-03-3114129774core:NetGoodwill2024-04-012025-03-3114129774core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114129774core:ListedExchangeTraded2024-04-012025-03-3114129774core:UnlistedNon-exchangeTraded2024-04-012025-03-3114129774core:MoreThanFiveYears2024-04-012025-03-3114129774core:Non-currentFinancialInstruments2025-03-3114129774core:Non-currentFinancialInstruments2024-03-3114129774dpl:CostSales2024-04-012025-03-3114129774dpl:DistributionCosts2024-04-012025-03-3114129774core:LandBuildings2024-04-012025-03-3114129774core:PlantMachinery2024-04-012025-03-3114129774core:Vehicles2024-04-012025-03-3114129774core:FurnitureFittings2024-04-012025-03-3114129774core:OfficeEquipment2024-04-012025-03-3114129774dpl:AdministrativeExpenses2024-04-012025-03-3114129774core:NetGoodwill2024-04-012025-03-3114129774core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114129774dpl:GroupUndertakings2024-04-012025-03-3114129774dpl:ParticipatingInterests2024-04-012025-03-3114129774dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114129774core:ListedExchangeTraded2024-04-012025-03-3114129774dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114129774core:UnlistedNon-exchangeTraded2024-04-012025-03-3114129774dpl:CostSales2023-06-012024-03-3114129774dpl:DistributionCosts2023-06-012024-03-3114129774core:LandBuildings2023-06-012024-03-3114129774core:PlantMachinery2023-06-012024-03-3114129774core:Vehicles2023-06-012024-03-3114129774core:FurnitureFittings2023-06-012024-03-3114129774core:OfficeEquipment2023-06-012024-03-3114129774dpl:AdministrativeExpenses2023-06-012024-03-3114129774core:NetGoodwill2023-06-012024-03-3114129774core:IntangibleAssetsOtherThanGoodwill2023-06-012024-03-3114129774dpl:GroupUndertakings2023-06-012024-03-3114129774dpl:ParticipatingInterests2023-06-012024-03-3114129774dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-03-3114129774core:ListedExchangeTraded2023-06-012024-03-3114129774dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-03-3114129774core:UnlistedNon-exchangeTraded2023-06-012024-03-3114129774core:NetGoodwill2025-03-3114129774core:IntangibleAssetsOtherThanGoodwill2025-03-3114129774core:LandBuildings2025-03-3114129774core:PlantMachinery2025-03-3114129774core:Vehicles2025-03-3114129774core:FurnitureFittings2025-03-3114129774core:OfficeEquipment2025-03-3114129774core:AfterOneYear2025-03-3114129774core:WithinOneYear2025-03-3114129774core:ListedExchangeTraded2025-03-3114129774core:UnlistedNon-exchangeTraded2025-03-3114129774core:ShareCapital2025-03-3114129774core:SharePremium2025-03-3114129774core:RevaluationReserve2025-03-3114129774core:OtherReservesSubtotal2025-03-3114129774core:RetainedEarningsAccumulatedLosses2025-03-3114129774core:NetGoodwill2024-03-3114129774core:IntangibleAssetsOtherThanGoodwill2024-03-3114129774core:LandBuildings2024-03-3114129774core:PlantMachinery2024-03-3114129774core:Vehicles2024-03-3114129774core:FurnitureFittings2024-03-3114129774core:OfficeEquipment2024-03-3114129774core:AfterOneYear2024-03-3114129774core:WithinOneYear2024-03-3114129774core:ListedExchangeTraded2024-03-3114129774core:UnlistedNon-exchangeTraded2024-03-3114129774core:ShareCapital2024-03-3114129774core:SharePremium2024-03-3114129774core:RevaluationReserve2024-03-3114129774core:OtherReservesSubtotal2024-03-3114129774core:RetainedEarningsAccumulatedLosses2024-03-3114129774core:NetGoodwill2023-05-3114129774core:IntangibleAssetsOtherThanGoodwill2023-05-3114129774core:LandBuildings2023-05-3114129774core:PlantMachinery2023-05-3114129774core:Vehicles2023-05-3114129774core:FurnitureFittings2023-05-3114129774core:OfficeEquipment2023-05-3114129774core:AfterOneYear2023-05-3114129774core:WithinOneYear2023-05-3114129774core:ListedExchangeTraded2023-05-3114129774core:UnlistedNon-exchangeTraded2023-05-3114129774core:ShareCapital2023-05-3114129774core:SharePremium2023-05-3114129774core:RevaluationReserve2023-05-3114129774core:OtherReservesSubtotal2023-05-3114129774core:RetainedEarningsAccumulatedLosses2023-05-3114129774core:AfterOneYear2024-04-012025-03-3114129774core:WithinOneYear2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114129774core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114129774core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114129774core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114129774core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114129774core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114129774core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114129774core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114129774core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114129774core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114129774core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114129774core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114129774bus:Director12024-04-012025-03-3114129774bus:Director22024-04-012025-03-31

Brows and Aesthetics by Lou Limited

Registered Number
14129774
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

Brows and Aesthetics by Lou Limited
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Mr A Howarth
Mrs L Howarth

Registered Address

C/O 7m Accountancy 9 Brandon Avenue
Heald Green
Cheadle
SK8 3SG

Registered Number

14129774 (England and Wales)
Brows and Aesthetics by Lou Limited
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets32,7505,500
Tangible assets410,7311,291
13,4816,791
Current assets
Debtors3,8635,706
Cash at bank and on hand9,3349,676
13,19715,382
Creditors amounts falling due within one year(26,887)(41,004)
Net current assets (liabilities)(13,690)(25,622)
Total assets less current liabilities(209)(18,831)
Provisions for liabilities(2,039)-
Net assets(2,248)(18,831)
Capital and reserves
Called up share capital100100
Profit and loss account(2,348)(18,931)
Shareholders' funds(2,248)(18,831)
The financial statements were approved and authorised for issue by the Board of Directors on 12 December 2025, and are signed on its behalf by:
Mrs L Howarth
Director
Registered Company No. 14129774
Brows and Aesthetics by Lou Limited
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Going concern
During the year the directors have introduced funds in order to support the company’s working capital requirements. The directors have given assurances that the director’s current account will not be drawn down to the detriment of the company’s creditors or cash flow and the director considers that the company is a going concern for at least 12 months from the date the financial statements are issued. On this basis, the financial statements have been prepared on a going concern basis.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
The company's policy of revenue recognition is to recognise a sale when the contractual obligations to the customer have been fulfilled. For contracts where obligations to the customer have not been fulfilled, but have been invoiced the sale is recognised within deferred income in current liabilities until such time a right to consideration arises. The total turnover of the company for the year has been derived from its principal activity wholly undertaken within the United Kingdom.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Current taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be four years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
Financial instruments
A financial asset or financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit or loss. All other investments are subsequently measured at cost less impairment. Debtors and creditors which fall due within one year are recorded in the financial statements at transaction price and subsequently measured at amortised cost. If the effects of the time value of money are immaterial, they are measured at cost (less impairment for trade debtors). Debtors are reviewed for impairment at each reporting date and any impairments are recorded in profit or loss and shown within administrative expenses when there is objective evidence that a debtor is impaired. Objective evidence that a debtor is impaired arises when the customer is unable to settle amounts owing to the company or the customer becomes bankrupt. Debtors do not carry interest and are stated at their nominal value. Trade creditors are not interest-bearing and are stated at their nominal value. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.
2.Average number of employees

20252024
Average number of employees during the year12
3.Intangible assets

Total

£
Cost or valuation
At 01 April 2411,000
At 31 March 2511,000
Amortisation and impairment
At 01 April 245,500
Charge for year2,750
At 31 March 258,250
Net book value
At 31 March 252,750
At 31 March 245,500
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 242,296
Additions9,970
At 31 March 2512,266
Depreciation and impairment
At 01 April 241,004
Charge for year531
At 31 March 251,535
Net book value
At 31 March 2510,731
At 31 March 241,291